These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20800114)

  • 1. HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen.
    Saenz R; Souza Cda S; Huang CT; Larsson M; Esener S; Messmer D
    Vaccine; 2010 Nov; 28(47):7556-62. PubMed ID: 20800114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines.
    Talebi S; Bolhassani A; Azad TM; Arashkia A; Modaresi MH
    Protein Pept Lett; 2017; 24(3):190-196. PubMed ID: 28000571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization.
    Saenz R; Messmer B; Futalan D; Tor Y; Larsson M; Daniels G; Esener S; Messmer D
    Mol Immunol; 2014 Feb; 57(2):191-9. PubMed ID: 24172222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant.
    Saenz R; Futalan D; Leutenez L; Eekhout F; Fecteau JF; Sundelius S; Sundqvist S; Larsson M; Hayashi T; Minev B; Carson D; Esener S; Messmer B; Messmer D
    J Transl Med; 2014 Aug; 12():211. PubMed ID: 25123824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells.
    Muthumani G; Laddy DJ; Sundaram SG; Fagone P; Shedlock DJ; Kannan S; Wu L; Chung CW; Lankaraman KM; Burns J; Muthumani K; Weiner DB
    Immunology; 2009 Sep; 128(1 Suppl):e612-20. PubMed ID: 19740322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity.
    Milani A; Bolhassani A; Shahbazi S; Motevalli F; Sadat SM; Soleymani S
    Immunol Lett; 2017 Nov; 191():16-22. PubMed ID: 28917624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of HCV Therapeutic Vaccines Using Hp91 Peptide and Small Heat Shock Protein 20 as an Adjuvant.
    Basirnejad M; Bolhassani A
    Protein Pept Lett; 2018; 25(10):924-932. PubMed ID: 30255740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hp91 immunoadjuvant: An HMGB1-derived peptide for development of therapeutic HPV vaccines.
    Talebi S; Bolhassani A; Sadat SM; Vahabpour R; Agi E; Shahbazi S
    Biomed Pharmacother; 2017 Jan; 85():148-154. PubMed ID: 27930979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.
    Demircan MB; Tohumeken S; Gunduz N; Khalily MA; Tekinay T; Guler MO; Tekinay AB
    Biotechnol J; 2020 Dec; 15(12):e2000100. PubMed ID: 32679620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple nanoliposomes encapsulating
    Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of tilapia alpha-helical antimicrobial peptides with subunit antigens boost immunogenicity in mice and tilapia (Oreochromis niloticus).
    Acosta J; Carpio Y; Valdés I; Velázquez J; Zamora Y; Morales R; Morales A; Rodríguez E; Estrada MP
    Vaccine; 2014 Jan; 32(2):223-9. PubMed ID: 24252704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu.
    Salem ML; El-Naggar SA; Kadima A; Gillanders WE; Cole DJ
    Vaccine; 2006 Jun; 24(24):5119-32. PubMed ID: 16704888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
    Schmidt ST; Olsen CL; Franzyk H; Wørzner K; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
    Eur J Pharm Biopharm; 2019 Jul; 140():29-39. PubMed ID: 31055066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A surfactin cyclopeptide of WH1fungin used as a novel adjuvant for intramuscular and subcutaneous immunization in mice.
    Gao Z; Wang S; Qi G; Pan H; Zhang L; Zhou X; Liu J; Zhao X; Wu J
    Peptides; 2012 Nov; 38(1):163-71. PubMed ID: 22982610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.
    Korsholm KS; Hansen J; Karlsen K; Filskov J; Mikkelsen M; Lindenstrøm T; Schmidt ST; Andersen P; Christensen D
    Vaccine; 2014 Jun; 32(31):3927-35. PubMed ID: 24877765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.
    Mosaheb M; Wetzler LM
    Vaccine; 2018 Nov; 36(50):7689-7699. PubMed ID: 30381152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses.
    Krishnan L; Deschatelets L; Stark FC; Gurnani K; Sprott GD
    Clin Dev Immunol; 2010; 2010():578432. PubMed ID: 21318177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity.
    Uto T; Wang X; Sato K; Haraguchi M; Akagi T; Akashi M; Baba M
    J Immunol; 2007 Mar; 178(5):2979-86. PubMed ID: 17312143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.